abstract |
The present invention relates to the use of linear ketophosphonate compounds to decrease cholesterol and lipids in patients, including those that have been shown not to respond to statins, using the linear ketophosphonates alone or in combination with a statin and also use of linear ketophosphonates to decrease the production of β-amyloid protein. |